The institute seminar on Wednesday April 2nd will was held by the distinguished guest lecturer dr. Paul S. Meltzer, Head of the Molecular Genetics Section and Branch Chief at the Center for Cancer Research, National Cancer Institute, U.S.
Title of his talk: Bringing the New Sequencing Technologies to the Oncology Clinic: Opportunities and Challenges
Published in major journals, first or last author from Oslo University Hospital.
Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy
Ann Oncol, 29 Suppl 5, v109
An emerging focus on lipids in extracellular vesicles
Adv Drug Deliv Rev (in press)
Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial
Lancet, 395 (10228), 951-961